Although external devices for the monitoring and administration of insulin have improved glycemic control and metabolic control in patients with diabetes, insulin is so tightly regulated by the body that it still exceeds the capabilities of increasingly sophisticated forms of subcutaneous administration. The gene discussed is INS; the disease is diabetes mellitus.